Can Oncomatryx OMTX305 overcome immune resistance in solid tumors?
Oncomatryx OMTX305 activates T cells and destroys tumor-supporting fibroblasts in preclinical cancer models. Examine the findings and limitations.
Oncomatryx OMTX305 activates T cells and destroys tumor-supporting fibroblasts in preclinical cancer models. Examine the findings and limitations.
Read how Insulet’s Omnipod 5 Spain launch could reshape tubeless insulin delivery, reimbursement and connected diabetes care.